W

    Waldencast Acquisition Corp (WALD)

    Official site

    CONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NASDAQ

    $1.39
    +0.05 (+3.73%)

    Market Cap: $171.87M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    44%(7/16)
    Avg Surprise
    -643.27%
    Streak
    3 Q
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    		$N/A$-0.26N/ABeat-
    Mar 26
    		$0.00N/A+100.00%Beat+100.0%
    Dec 25
    		$0.00N/A+100.00%Beat+100.0%
    Sep 25
    		$-0.11$-0.11+0.00%Beat-22.2%
    Jun 25
    		$-0.09$-0.07-28.57%Miss-80.0%
    Mar 25
    		$-0.17$-0.04-347.37%Miss+65.3%
    Dec 24
    		$-0.28$-0.05-434.35%Miss+42.9%
    Sep 24
    		$-0.09$-0.05-80.00%Miss-
    Jun 24
    		$-0.05$-0.03-66.67%Miss-168.2%
    Mar 24
    		$-0.49$-0.01-4800.00%Miss-2060.0%
    Dec 23
    		$-0.49$-0.01-4800.00%Miss-2060.0%
    Sep 23
    		$0.00N/A+100.00%Beat+100.0%
    Jun 23
    		$0.07$0.07+4.71%Beat+22.2%
    Mar 23
    		$0.03$-0.01+350.00%Beat-64.3%
    Dec 22
    		$0.03$-0.01+350.00%Beat+105.7%
    Sep 22
    		$-0.06$0.01-700.00%Miss-133.3%
    Jun 22
    		$0.06$0.10-40.00%Miss+300.0%
    Mar 22
    		$0.07N/AN/ABeat+294.4%
    Dec 21
    		$-0.44N/AN/ABeat-1500.0%
    Sep 21
    		$0.18N/AN/ABeat-
    Jun 21
    		$-0.03N/AN/ABeat-
    Mar 21
    		$-0.04$0.00N/AMiss-
    Dec 20
    		$-0.03$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-2.14EV/EBITDA13.88x
    Price/FCF-5.92xFCF Yield-16.90%
    Profitability
    Profit Margin-84.50%Operating Margin-22.50%
    ROE-40.30%ROIC-16.01%
    Financial Health
    Debt/Equity0.30xInterest Coverage-2.44x
    Current Ratio1.70xQuick Ratio0.97x
    Trading Statistics
    Beta-0.04Avg Volume227.62K
    52-Week High$3.2252-Week Low$0.72

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.35
    SMA 20$1.37
    SMA 50$1.55
    SMA 200$1.60
    EMA 10$1.36
    EMA 20$1.40
    EMA 50$1.48
    EMA 200$1.63

    MACD

    Line: -0.06Signal: -0.07Hist: 0.01

    ADX

    ADX: 16.1+DI: 17.4-DI: 15.8

    Aroon & PSAR

    Aroon Up16.0
    Aroon Down76.0
    PSAR$1.28

    Bollinger Bands

    Upper Band$1.49
    Lower Band$1.25
    %B Position1764%(Upper)
    Band Width0.58

    RSI (14-Day)

    Neutral
    45.4

    Momentum Oscillators

    Stoch %K64.0
    Stoch %D57.7
    Williams %R-18.8
    ROC (10d)2.2%
    Momentum0.03
    CCI (20d)-6.6
    MFI (14d)46.9

    Volatility Measures

    ATR (14d)$0.09(6.4%)
    StdDev (20d)0.06
    Hist Vol54.8%(High)

    Volume Flow

    VWAP$1.37
    OBV-25.0M
    AD Line-33.2M
    CMF (20d)-0.067

    Volume Metrics

    Avg Vol (20d)209.0K
    Vol Ratio0.4x(Low)
    VWMA (20d)$1.38

    Pivot Points

    R3$1.38
    R2$1.37
    R1$1.36
    Pivot Point$1.34
    S1$1.33
    S2$1.32
    S3$1.30

    Advanced Oscillators

    TSI-21.24
    Ultimate Osc59.5
    KST-175.91

    Financial Data

    QuarterDec 2025Jun 2025Dec 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Sep 2022Jun 2022Mar 2022
    Total Revenue$139.80M$132.27M$142.29M$131.58M$108.80M$89.85M$54.40M$109.34M$54.67M$76.28M$0$76.28M
    Cost of Revenue$78.41M$69.83M$44.72M$37.40M$35.40M$86.20M$17.70M$41.16M$20.58M$40.50M$4.00M$40.50M
    Gross Profit$61.39M$62.45M$97.57M$94.18M$73.40M$3.66M$36.70M$68.18M$34.09M$35.78M$-4,003,477$35.78M
    Operating Expenses$91.70M$93.81M$128.64M$121.68M$120.10M$57.98M$67.50M$100.62M$51.70M$47.32M$4.40M$55.72M
    R&D$0$0$1.80M$1.80M$475,000$2.67M$237,500$2.72M$1.36M$1.74M$0$1.74M
    SG&A$0$0$81.92M$119.88M$106.52M$4.00M$0$0$0$0$4.40M$4.00M
    Operating Income$-30,311,000$-31,364,000$-31,078,000$-27,506,000$-46,704,000$-54,324,000$-23,352,000$-35,227,000$-17,613,500$-11,544,000$-4,397,526$-19,945,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$257,251$4,059
    Interest Expense$12.40M$12.70M$8.44M$8.71M$10.06M$9.61M$12.47M$8.85M$3.03M$3.27M$7.03M$3.27M
    Income Before Tax$-68,043,000$-194,202,000$-33,279,000$-15,259,000$-71,654,000$-138,981,000$-35,827,000$-41,289,000$-20,644,500$-14,113,000$2.77M$-8,323,000
    Income Tax Expense$-5,213,000$-8,976,000$2.46M$-2,353,000$-2,466,000$-6,583,000$1.23M$-4,509,000$2.25M$893,000$-257,251$893,000
    Net Income$-60,310,000$-169,439,000$-32,368,000$-10,075,000$-78,209,000$-107,151,000$-39,104,500$-11,772,000$-14,707,000$-15,263,000$2.77M$-9,473,000
    EBITDA$-1,151,000$-151,483,000$-1,124,000$1.73M$-18,484,000$-106,216,000$-17,605,500$-23,734,000$-3,668,500$1.18M$21.89M$6.97M
    EBIT$-30,311,000$-181,507,000$-26,047,000$-27,506,000$-46,704,000$-129,373,000$-23,352,000$-35,227,000$-17,613,500$-10,839,000$-4,397,526$-5,049,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about WALD

    News

    Waldencast plc (WALD) repurchases 193,816 RSUs as Hind Sebti moves to Obagi

    Waldencast plc reported the repurchase of 193,816 Restricted Stock Units (RSUs) from its Chief Growth Officer, Hind Sebti, at $2.00 per RSU. This transaction occurred in connection with the sale of Waldencast's Obagi Medical business, which Sebti is now leading. Following this disposition, Sebti holds no remaining RSUs from an original grant made in October 2024.

    Stock Titan•8/7/26•
    Neutral

    Waldencast (WALD) investors approve directors, auditor and share repurchase

    Waldencast plc shareholders approved the reappointment of three Class I directors, ratified Deloitte & Touche LLP as the independent auditor, and authorized a five-year share repurchase program for both Class A and Class B ordinary shares. These decisions were made at the annual general meeting on August 4, 2026, with 72.90% of outstanding shares represented. The repurchase authority allows the company to hold repurchased shares as treasury shares.

    Stock Titan•8/5/26•
    Somewhat-Bullish

    Discover TROOPS And 2 Other Promising Penny Stocks

    This article identifies three promising penny stocks: TROOPS (TROO), Waldencast (WALD), and Expensify (EXFY). It highlights their operations, market capitalization, financial health ratings, and recent developments. The analysis suggests these companies offer growth potential for investors looking at affordable stocks, despite some currently being unprofitable, due to factors like positive free cash flow and strategic market advancements.

    Sahm•7/16/26•
    Neutral

    [6-K] Waldencast plc Current Report (Foreign Issuer) | WALD SEC Filing - Form 6-K

    Waldencast plc (NASDAQ: WALD) announced its 2026 Annual General Meeting to be held on August 4, 2026, in London. The company also disclosed board changes linked to the sale of Obagi Medical, with Michel Brousset and Hind Sebti resigning and Mazdack Rassi being appointed. Following the Obagi Medical sale, expected in Q3 2026, Waldencast plans to focus on growing its Milk Makeup brand.

    Stock Titan•7/13/26•
    Neutral

    Waldencast plc Class A Actuals & Estimates (BOATS:WALD)

    This article provides financial actuals and estimates for Waldencast plc (BOATS:WALD), including an overview of analyst price targets, historical highs and lows, and recent financial performance. It highlights that analysts project a maximum price of 3.00 USD and a minimum of 1.60 USD for WALD, and notes the company's net income for the last half-year was -60.31M USD, with 367 employees as of June 27, 2026.

    TradingView•6/27/26•
    Neutral

    Frequently Asked Questions About WALD

    Does WALD pay dividends?
    Waldencast Acquisition Corp (WALD) does not currently pay a regular dividend.
    What is WALD's market cap?
    Waldencast Acquisition Corp (WALD) has a market capitalization of $171.87M with a current stock price of $1.39.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In